Concepedia

On-demand biomanufacturing of protective conjugate vaccines

Jessica C. Stark, Thapakorn Jaroentomeechai, Tyler D. Moeller, Jasmine M. Hershewe, Katherine F. Warfel, Bridget S. Moricz, Anthony M. Martini, Rachel S. Dubner, Karen J. Hsu, Taylor C. Stevenson,

Science Advances · 2021 · 131 citations · 65 references

DOIFull text

Open access

Concepts

Abstract

challenge. The iVAX platform promises to accelerate development of new conjugate vaccines with increased access through refrigeration-independent distribution and portable production.

References

65

One-step inactivation of chromosomal genes in <i>Escherichia coli</i> K-12 using PCR products

Kirill A. Datsenko, Barry L. Wanner · Proceedings of the National Academy of Sciences · 2000 · 15.2K citations · Full text

, , +17

Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15

Brian Wahl, Katherine L. O’Brien, Adena Greenbaum et al. · The Lancet Global Health · 2018 · 1.2K citations · Full text

, , +17

Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine

Katherine A. Poehling, Thomas R. Talbot, Marie R. Griffin et al. · JAMA · 2006 · 466 citations

, , +17

Mimicking the <i>Escherichia coli</i> cytoplasmic environment activates long‐lived and efficient cell‐free protein synthesis

Michael C. Jewett, James R. Swartz · Biotechnology and Bioengineering · 2004 · 456 citations

, , +17

Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in <i>Escherichia coli</i>

Mario F. Feldman, Michael Wacker, Marcela Hernandez et al. · Proceedings of the National Academy of Sciences · 2005 · 455 citations · Full text

, , +17